| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |